Lurasidone hydrochloride

CAS: 367514-88-3

Ref. 3D-FL24958

Produktinformation

• Name: Lurasidone hydrochloride
• Synonyme: (3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindol e-1,3(2H)-dione hydrochlorideLatuda, SM 13496, 4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-, (3aR,4S,7R,7aS)- hydrochloride, 4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-, hydrochloride (1:1), (3aR,4S,7R,7aS)-, 4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-, monohydrochloride, (3aR,4S,7R,7aS)-, Latuda, Lurasidone HCl, Lurasidone Hydrochloride, Sm 13496
• CAS: 367514-88-3

Beschreibung

Lurasidone hydrochloride is a drug that belongs to the class of atypical antipsychotics. It is used in the treatment of schizophrenia. Lurasidone hydrochloride has been shown to have a high affinity for 5-HT7 receptors and may also inhibit P-glycoprotein (P-gp) activity, which could be beneficial in treating treatment-resistant schizophrenia. The drug has been shown to bind to both dopamine D2 and serotonin 5-HT2A receptors and has structural features similar to ziprasidone. Lurasidone hydrochloride also inhibits monoamine oxidase A (MAO-A), as well as other enzymes such as CYP3A4, CYP1A2, and CYP2D6.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 529.14 g/mol
• Formel: C₂₈H₃₇ClN₄O₂S
• Reinheit: Min. 95%
• Farbe/Form: Powder